Study Estimates Global Burden of Vertically Transmitted Hepatitis C
By Lori Solomon HealthDay Reporter
TUESDAY, Aug. 5, 2025 -- Each year, nearly 74,000 children are born with hepatitis C virus (HCV) around the world, according to a study published online July 23 in The Lancet Gastroenterology and Hepatology.
Adam Trickey, Ph.D., from the University of Bristol in the United Kingdom, and colleagues estimated the annual number of vertically transmitted HCV infections and how many cases remain at 5 years of age globally and regionally.
The researchers found that the estimated annual global number of new HCV infections occurring through vertical transmission was 73,862, with the most infections seen in Southern Asia (21,245), Western Africa (16,482), and Eastern Africa (8,182). At the country level, Pakistan (16,350) and Nigeria (8,483) had the largest burden and together accounted for about one-third of new infections. Estimates project that 23,120 of these children would be alive and still have HCV at age 5 years.
"These statistics are important for policymakers and health care planners as they uncover a major source of new HCV infections that has so far been understudied," Trickey said in a statement. "There are also implications for service delivery, as pregnancy is often a time where it is possible for health care providers to engage with people who they might not usually be in contact with, offering a chance to screen them for HCV and connect them to care if necessary."
Several authors disclosed ties to relevant organizations.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2025
Read this next
AAP Updates Screening Guidance for Child Mental Health, Behavioral Problems
MONDAY, Aug. 25, 2025 -- In a clinical report issued by the American Academy of Pediatrics and published online Aug. 25 in Pediatrics, updated recommendations are presented for...
Discordance Seen Between Care Goals, Treatment Intent in Advanced Cancer
MONDAY, Aug. 25, 2025 -- More patients with advanced cancer report that their treatment discordantly focuses on longevity over comfort than patients with other illnesses...
Apitegromab Improves Motor Function in Spinal Muscular Atrophy
MONDAY, Aug. 25, 2025 -- For patients with nonambulatory type 2 or type 3 spinal muscular atrophy, apitegromab, a monoclonal antibody that inhibits myostatin activation, improves...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.